9-134785950-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000093.5(COL5A1):​c.2593-45G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0556 in 1,555,858 control chromosomes in the GnomAD database, including 3,126 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.079 ( 714 hom., cov: 33)
Exomes 𝑓: 0.053 ( 2412 hom. )

Consequence

COL5A1
NM_000093.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.131

Publications

5 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 9-134785950-G-A is Benign according to our data. Variant chr9-134785950-G-A is described in ClinVar as Benign. ClinVar VariationId is 255066.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.156 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A1NM_000093.5 linkc.2593-45G>A intron_variant Intron 30 of 65 ENST00000371817.8 NP_000084.3 P20908-1A0A024R8E5B2ZZ86Q59EE7
COL5A1NM_001278074.1 linkc.2593-45G>A intron_variant Intron 30 of 65 NP_001265003.1 B2ZZ86Q59EE7
COL5A1XM_017014266.3 linkc.2593-45G>A intron_variant Intron 30 of 64 XP_016869755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A1ENST00000371817.8 linkc.2593-45G>A intron_variant Intron 30 of 65 1 NM_000093.5 ENSP00000360882.3 P20908-1
COL5A1ENST00000371820.4 linkc.2593-45G>A intron_variant Intron 30 of 65 2 ENSP00000360885.4 P20908-2H7BY82

Frequencies

GnomAD3 genomes
AF:
0.0795
AC:
12090
AN:
152104
Hom.:
714
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.159
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0339
Gnomad ASJ
AF:
0.0565
Gnomad EAS
AF:
0.117
Gnomad SAS
AF:
0.0309
Gnomad FIN
AF:
0.0556
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0481
Gnomad OTH
AF:
0.0689
GnomAD2 exomes
AF:
0.0569
AC:
13727
AN:
241424
AF XY:
0.0536
show subpopulations
Gnomad AFR exome
AF:
0.162
Gnomad AMR exome
AF:
0.0225
Gnomad ASJ exome
AF:
0.0581
Gnomad EAS exome
AF:
0.125
Gnomad FIN exome
AF:
0.0592
Gnomad NFE exome
AF:
0.0476
Gnomad OTH exome
AF:
0.0487
GnomAD4 exome
AF:
0.0530
AC:
74404
AN:
1403636
Hom.:
2412
Cov.:
25
AF XY:
0.0522
AC XY:
36621
AN XY:
701322
show subpopulations
African (AFR)
AF:
0.166
AC:
5350
AN:
32290
American (AMR)
AF:
0.0247
AC:
1086
AN:
44028
Ashkenazi Jewish (ASJ)
AF:
0.0588
AC:
1511
AN:
25704
East Asian (EAS)
AF:
0.111
AC:
4341
AN:
39204
South Asian (SAS)
AF:
0.0337
AC:
2830
AN:
83924
European-Finnish (FIN)
AF:
0.0567
AC:
2986
AN:
52676
Middle Eastern (MID)
AF:
0.0524
AC:
298
AN:
5690
European-Non Finnish (NFE)
AF:
0.0494
AC:
52477
AN:
1061590
Other (OTH)
AF:
0.0602
AC:
3525
AN:
58530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
3543
7086
10629
14172
17715
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2098
4196
6294
8392
10490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0795
AC:
12100
AN:
152222
Hom.:
714
Cov.:
33
AF XY:
0.0771
AC XY:
5740
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.159
AC:
6611
AN:
41516
American (AMR)
AF:
0.0339
AC:
519
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0565
AC:
196
AN:
3466
East Asian (EAS)
AF:
0.117
AC:
607
AN:
5172
South Asian (SAS)
AF:
0.0303
AC:
146
AN:
4822
European-Finnish (FIN)
AF:
0.0556
AC:
590
AN:
10606
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0481
AC:
3272
AN:
68024
Other (OTH)
AF:
0.0682
AC:
144
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
562
1124
1685
2247
2809
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0332
Hom.:
29
Bravo
AF:
0.0821
Asia WGS
AF:
0.0790
AC:
276
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.41
DANN
Benign
0.82
PhyloP100
0.13
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45497895; hg19: chr9-137677796; COSMIC: COSV65664826; API